短疗程与长疗程抗生素治疗儿童非重症社区获得性肺炎:系统综述与荟萃分析
结果显示,短疗程口服抗生素在治疗失败方面非劣于长疗程(风险比1.01,95%CI 0.92-1.11),且与更少的胃肠炎报告和更低看护者缺勤相关。临床医生应考虑为儿童非重症社区获得性肺炎处方短疗程抗生素。
要点
- 短疗程口服抗生素治疗儿童非重症社区获得性肺炎在治疗失败方面非劣于长疗程。
- 3天疗程非劣于5天疗程,5天疗程非劣于10天疗程(治疗失败结局)。
- 短疗程与更少的胃肠炎报告和更低看护者缺勤相关。
核心结论
- 短疗程抗生素在2至59个月非重症社区获得性肺炎患儿中非劣于长疗程。
研究设计与样本
- 检索MEDLINE、Embase、Web of Science、Cochrane Library及3个中文数据库自建库至2022年3月31日,并检索临床试验注册平台和Google.com。
- 纳入比较相同口服抗生素短疗程与长疗程的随机临床试验,采用随机效应模型合并数据,使用GRADE评价证据质量。
主要发现
- 短疗程口服抗生素在治疗失败方面非劣于长疗程(风险比1.01,95%CI 0.92-1.11;风险差0.00,95%CI -0.01至0.01;I2=0%),证据质量高。
- 3天疗程非劣于5天疗程(风险比1.01,95%CI 0.91-1.12;I2=0%),5天疗程非劣于10天疗程(风险比0.87,95%CI 0.50-1.53;I2=0%)。
- 短疗程与更少的胃肠炎报告相关(风险比0.79,95%CI 0.66-0.95),与更低看护者缺勤相关(发生率比0.74,95%CI 0.65-0.84)。
关键数值与推荐
- 治疗失败定义为肺炎持续或新出现任何社区获得性肺炎一般危险征象(如嗜睡、意识不清、惊厥或不能饮水)、完成治疗后体温升高(>38°C)、更换抗生素、住院、死亡、漏服研究药物超过3次、失访或撤回知情同意。
临床怎么用
- 临床医生应考虑为儿童非重症社区获得性肺炎处方短疗程抗生素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Short-course antibiotic therapy could enhance adherence and reduce adverse drug effects and costs. However, based on sparse evidence, most guidelines recommend a longer course of antibiotics for nonsevere childhood community-acquired pneumonia (CAP). OBJECTIVE: To determine whether a shorter course of antibiotics was noninferior to a longer course for childhood nonsevere CAP. DATA SOURCES: MEDLINE, Embase, Web of Science, the Cochrane Library, and 3 Chinese databases from inception to March 31, 2022, as well as clinical trial registries and Google.com. STUDY SELECTION: Randomized clinical trials comparing a shorter- vs longer-course therapy using the same oral antibiotic for children with nonsevere CAP were included. DATA EXTRACTION AND SYNTHESIS: Random-effects models were used to pool the data, which were analyzed from April 15, 2022, to May 15, 2022. Grading of Recommendations Assessment, Development and Evaluation (GRADE) was used to rate the quality of the evidence. MAIN OUTCOMES AND MEASURES: Treatment failure, defined by persistence of pneumonia or the new appearance of any general danger signs of CAP (eg, lethargy, unconsciousness, seizures, or inability to drink), elevated temperature (>38 °C) after completion of treatment, change of antibiotic, hospitalization, death, missing more than 3 study drug doses, loss to follow-up, or withdrawal of informed consent. RESULTS: Nine randomized clinical trials including 11 143 participants were included in this meta-analysis. A total of 98% of the participants were aged 2 to 59 months, and 58% were male. Eight studies with 10 662 patients reported treatment failure. Treatment failure occurred in 12.8% vs 12.6% of participants randomized to a shorter vs a longer course of antibiotics. High-quality evidence showed that a shorter course of oral antibiotic was noninferior to a longer course with respect to treatment failure for children with nonsevere CAP (risk ratio, 1.01; 95% CI, 0.92-1.11; risk difference, 0.00; 95% CI, -0.01 to 0.01; I2 = 0%). A 3-day course of antibiotic treatment was noninferior to a 5-day course for the outcome of treatment failure (risk ratio, 1.01; 95% CI, 0.91-1.12; I2 = 0%), and a 5-day course was noninferior to a 10-day course (risk ratio, 0.87; 95% CI, 0.50-1.53; I2 = 0%). A shorter course of antibiotics was associated with fewer reports of gastroenteritis (risk ratio, 0.79; 95% CI, 0.66-0.95) and lower caregiver absenteeism (incident rate ratio, 0.74; 95% CI, 0.65-0.84). CONCLUSIONS AND RELEVANCE: Results of this meta-analysis suggest that a shorter course of antibiotics was noninferior to a longer course in children aged 2 to 59 months with nonsevere CAP. Clinicians should consider prescribing a shorter course of antibiotics for the management of pediatric nonsevere CAP.
引用
- Li Q, Zhou Q, Florez ID, et al. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. JAMA Pediatr. 2022. PMID: 36374480. doi:10.1001/jamapediatrics.2022.4123
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。